Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell C Posner

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial designMatthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2020
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasisDarren S Bryan, Melinda Stack, Katarzyna Krysztofiak, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
NPJ Precision Oncology|October 14, 2022
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapyLiam F Spurr, Carlos A Martinez, Rohan R Katipally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.
Medical Oncology (Northwood, London, England)|August 24, 2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junctionNicholas W Choong, Ann M Mauer, Daniel C Haraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type FibromatosisJia Hu, Meera R Hameed, Narasimhan P Agaram, et al.
Plos One|December 20, 2012
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsYves A Lussier, Nikolai N Khodarev, Kelly Regan, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Annals of Surgical Oncology|August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II TrialAlice C Wei, Fang-Shu Ou, Qian Shi, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial designMatthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2020
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasisDarren S Bryan, Melinda Stack, Katarzyna Krysztofiak, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
NPJ Precision Oncology|October 14, 2022
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapyLiam F Spurr, Carlos A Martinez, Rohan R Katipally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.
Medical Oncology (Northwood, London, England)|August 24, 2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junctionNicholas W Choong, Ann M Mauer, Daniel C Haraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type FibromatosisJia Hu, Meera R Hameed, Narasimhan P Agaram, et al.
Plos One|December 20, 2012
Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAsYves A Lussier, Nikolai N Khodarev, Kelly Regan, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Annals of Surgical Oncology|August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II TrialAlice C Wei, Fang-Shu Ou, Qian Shi, et al.
Pageof 13